Finance

Beta
Lists
MPLT:NASDAQ
MapLight Therapeutics Inc
$28.34
+3.66%
(+1.00) 1D
$28.34
0.00% (0.00)
After hours
Closed: Jun 3, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MPLT...
Open
$27.26
High
$28.37
Low
$25.66
Mkt. cap
1.29B
Avg. vol.
311.87K
Volume
25.00
52-wk high
$33.28
52-wk low
$12.25
Shares outstanding
42.62M
No. of employees
133
Open
$27.26
High
$28.37
Low
$25.66
Mkt. cap
1.29B
Avg. vol.
311.87K
Volume
25.00
52-wk high
$33.28
52-wk low
$12.25
Shares outstanding
42.62M
No. of employees
133
News stories
From sources across the web
About MapLight Therapeutics Inc
CEO-
Employees133
Founded2018
HeadquartersRedwood City, California, United States
SectorBiotechnology
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.34 / -$1.12
-19.91%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
26.85M
27.09M
64.62M
53.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.82M
4.40M
18.75M
10.82M
Operating expense
30.66M
31.50M
83.38M
64.50M
Total operating expenses
30.66M
31.50M
83.38M
64.50M
Operating income
-30.66M
-31.50M
-83.38M
-64.50M
Other non operating income
-66.00K
531.00K
-83.00K
549.00K
EBT including unusual items
-29.85M
-29.42M
-79.55M
-60.67M
EBT excluding unusual items
-30.04M
-29.42M
-80.99M
-61.48M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-29.85M
-29.42M
-79.55M
-60.67M
Net profit margin
-
-
-
-
Earnings per share
-
-
-2.47
-1.34
Interest and investment income
688.00K
1.55M
2.47M
2.47M
Interest expense
-
-
-
-
Net interest expenses
688.00K
1.55M
2.47M
2.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.53M
-31.36M
-83.24M
-64.34M
Gain or loss from assets sale
-
7.00K
-
4.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more